A Phase 1 Study to determine the effect of a high fat meal on the pharmacokinetics of Brivanib in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Brivanib alaninate (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 28 Dec 2011 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 27 Apr 2011 New trial record